123 related articles for article (PubMed ID: 37086688)
1. Discovering the digital biomarker of hepatocellular carcinoma in serum with SERS-based biosensors and intelligence vision.
Cheng N; Lou B; Wang H
Colloids Surf B Biointerfaces; 2023 Jun; 226():113315. PubMed ID: 37086688
[TBL] [Abstract][Full Text] [Related]
2. Sensitive multiplex detection of serological liver cancer biomarkers using SERS-active photonic crystal fiber probe.
Dinish US; Balasundaram G; Chang YT; Olivo M
J Biophotonics; 2014 Nov; 7(11-12):956-65. PubMed ID: 23963680
[TBL] [Abstract][Full Text] [Related]
3. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.
Luo P; Yin P; Hua R; Tan Y; Li Z; Qiu G; Yin Z; Xie X; Wang X; Chen W; Zhou L; Wang X; Li Y; Chen H; Gao L; Lu X; Wu T; Wang H; Niu J; Xu G
Hepatology; 2018 Feb; 67(2):662-675. PubMed ID: 28960374
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopy.
Xiao R; Zhang X; Rong Z; Xiu B; Yang X; Wang C; Hao W; Zhang Q; Liu Z; Duan C; Zhao K; Guo X; Fan Y; Zhao Y; Johnson H; Huang Y; Feng X; Xu X; Zhang H; Wang S
Nanomedicine; 2016 Nov; 12(8):2475-2484. PubMed ID: 27520725
[TBL] [Abstract][Full Text] [Related]
5. State-of-the-art Hepatocellular Carcinoma Biomarker Detection by Biosensor Technology-a Review.
Uygun ZO
J Gastrointest Cancer; 2021 Sep; 52(3):1081-1085. PubMed ID: 34347247
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
[TBL] [Abstract][Full Text] [Related]
7. Raman based hepatocellular carcinoma biomarker detection.
Santiago-Cordoba MA; Romano PR; MacKay A; Demirel MC
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3672-5. PubMed ID: 22255136
[TBL] [Abstract][Full Text] [Related]
8. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.
Guo Y; Zhao J; Bi J; Wu Q; Wang X; Lai Q
J Hematol Oncol; 2012 Jul; 5():37. PubMed ID: 22760167
[TBL] [Abstract][Full Text] [Related]
10. Dual-Selective and Dual-Enhanced SERS Nanoprobes Strategy for Circulating Hepatocellular Carcinoma Cells Detection.
Pang Y; Wang C; Xiao R; Sun Z
Chemistry; 2018 May; 24(27):7060-7067. PubMed ID: 29521467
[TBL] [Abstract][Full Text] [Related]
11. Well-Ordered Au Nanoarray for Sensitive and Reproducible Detection of Hepatocellular Carcinoma-Associated miRNA via CHA-Assisted SERS/Fluorescence Dual-Mode Sensing.
Huang X; Tian H; Huang L; Chen Q; Yang Y; Zeng R; Xu J; Chen S; Zhou X; Liu G; Li H; Zhang Y; Zhang J; Zheng J; Cai H; Zhou H
Anal Chem; 2023 Apr; 95(14):5955-5966. PubMed ID: 36916246
[TBL] [Abstract][Full Text] [Related]
12. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
13. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study.
Li GJ; Chen QY; Harrison TJ; Wang XY; Hu LP; Yang QL; Li KW; Fang ZL
Cancer Biomark; 2017; 18(3):241-248. PubMed ID: 28085009
[TBL] [Abstract][Full Text] [Related]
14. Multiplex Immunochips for High-Accuracy Detection of AFP-L3% Based on Surface-Enhanced Raman Scattering: Implications for Early Liver Cancer Diagnosis.
Ma H; Sun X; Chen L; Cheng W; Han XX; Zhao B; He C
Anal Chem; 2017 Sep; 89(17):8877-8883. PubMed ID: 28770990
[TBL] [Abstract][Full Text] [Related]
15. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
[TBL] [Abstract][Full Text] [Related]
16. Urine surface-enhanced Raman spectroscopy combined with SVM algorithm for rapid diagnosis of liver cirrhosis and hepatocellular carcinoma.
Dawuti W; Zheng X; Liu H; Zhao H; Dou J; Sun L; Chu J; Lin R; Lü G
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102811. PubMed ID: 35304310
[TBL] [Abstract][Full Text] [Related]
17. Identification of phenol 2,2-methylene bis, 6 [1,1-D] as breath biomarker of hepatocellular carcinoma (HCC) patients and its electrochemical sensing: E-nose biosensor for HCC.
Nazir NU; Abbas SR
Anal Chim Acta; 2023 Feb; 1242():340752. PubMed ID: 36657885
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Hu B; Tian X; Sun J; Meng X
Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
[TBL] [Abstract][Full Text] [Related]
19. An antibody-free liver cancer screening approach based on nanoplasmonics biosensing chips via spectrum-based deep learning.
Cheng N; Fu J; Chen D; Chen S; Wang H
NanoImpact; 2021 Jan; 21():100296. PubMed ID: 35559784
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on a combined test of multi serum biomarkers in China: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage.
Zhang K; Song P; Gao J; Li G; Zhao X; Zhang S
Drug Discov Ther; 2014 Jun; 8(3):102-9. PubMed ID: 25031041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
